Toxicogenomics Approaches to Address Toxicity and Carcinogenicity in the Liver.
Toxicol Pathol
; 51(7-8): 470-481, 2023 Oct.
Article
em En
| MEDLINE
| ID: mdl-38288963
ABSTRACT
Toxicogenomic technologies query the genome, transcriptome, proteome, and the epigenome in a variety of toxicological conditions. Due to practical considerations related to the dynamic range of the assays, sensitivity, cost, and technological limitations, transcriptomic approaches are predominantly used in toxicogenomics. Toxicogenomics is being used to understand the mechanisms of toxicity and carcinogenicity, evaluate the translational relevance of toxicological responses from in vivo and in vitro models, and identify predictive biomarkers of disease and exposure. In this session, a brief overview of various transcriptomic technologies and practical considerations related to experimental design was provided. The advantages of gene network analyses to define mechanisms were also discussed. An assessment of the utility of toxicogenomic technologies in the environmental and pharmaceutical space showed that these technologies are being increasingly used to gain mechanistic insights and determining the translational relevance of adverse findings. Within the environmental toxicology area, there is a broader regulatory consideration of benchmark doses derived from toxicogenomics data. In contrast, these approaches are mainly used for internal decision-making in pharmaceutical development. Finally, the development and application of toxicogenomic signatures for prediction of apical endpoints of regulatory concern continues to be area of intense research.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Toxicogenética
/
Fígado
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
Toxicol Pathol
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Estados Unidos